迈拓股份(301006) - 2022 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2022 reached ¥75,316,211.71, an increase of 16.97% compared to ¥64,386,900.56 in the same period last year[3] - Net profit attributable to shareholders was ¥30,878,591.86, reflecting a growth of 36.56% from ¥22,610,915.48 year-on-year[3] - Basic earnings per share increased by 2.40% to ¥0.2217, compared to ¥0.2165 in the same period last year[3] - Operating profit for the first quarter was CNY 36,952,412.31, up from CNY 26,795,393.28, indicating a growth of 37.5% year-over-year[19] - Total revenue from operating activities was CNY 113,356,598.25, compared to CNY 100,596,095.56 in the previous year, reflecting a growth of 12.6%[23] Cash Flow and Assets - The net cash flow from operating activities decreased by 24.51% to ¥7,729,458.55, down from ¥10,238,402.92 in the previous year[3] - Cash and cash equivalents at the end of Q1 2022 were CNY 160,854,271.45, down from CNY 668,926,828.29 at the beginning of the year[14] - The company reported a cash and cash equivalents balance of CNY 158,054,242.66 at the end of the quarter, a decrease from CNY 666,126,799.50 at the beginning of the quarter[24] - Total assets at the end of the reporting period were ¥1,213,964,969.59, a slight decrease of 0.08% from ¥1,214,980,048.19 at the end of the previous year[3] - Total liabilities decreased to CNY 103,565,840.32 from CNY 135,888,706.59 at the beginning of the year[16] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 9,400[8] - The top shareholder, Sun Weiguo, holds 36.48% of the shares, totaling 50,814,800 shares[8] - The company plans to lift restrictions on a total of 104,460,000 shares by June 2024, which may impact future liquidity and shareholder structure[11] Expenses and Investments - Total operating costs for Q1 2022 amounted to CNY 48,516,690.78, up from CNY 42,709,489.17 in the previous period[18] - Research and development expenses increased by 56.86%, indicating a focus on innovation and product development[6] - Research and development expenses for Q1 2022 were CNY 3,453,632.68, compared to CNY 2,201,661.26 in the previous period, reflecting a significant increase[18] - Investment income surged by 294.58%, primarily due to increased returns from financial products[6] - Investment activities resulted in a net cash outflow of CNY 515,802,015.39, compared to a net outflow of CNY 278,582,747.44 in the previous year, indicating increased investment activity[23] Other Financial Metrics - Other income increased to CNY 3,696,828.44 from CNY 2,703,191.83, marking a growth of 36.8% year-over-year[19] - The company incurred financial expenses of CNY -574,410.55, compared to CNY -108,370.36 in the previous year, indicating a significant increase in financial costs[19] - The company received CNY 2,102,746.44 in tax refunds, down from CNY 2,492,063.48 in the previous year, a decrease of 15.6%[23] - Inventory at the end of Q1 2022 was CNY 90,107,606.83, up from CNY 84,412,850.56 at the beginning of the year[14] - Accounts receivable at the end of Q1 2022 were CNY 190,967,832.43, slightly down from CNY 203,549,957.22 at the beginning of the year[14]